Clinical trial
Amifostine in Treating Young Patients With Newly Diagnosed De Novo…
NCT00098683 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00098683 |
|---|---|
| Title | Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes |
| Official title | A Phase II Study Of Amifostine In Children With Myelodysplastic Syndrome |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms |
| Intervention type | Drug |
| Interventions | amifostine trihydrate |
| Enrollment | 10 |
| Start date | Jan 1, 2005 |
| Primary completion | Oct 1, 2007 |
| Completion | Oct 1, 2009 |
| First posted | Dec 8, 2004 |
| Last update posted | Feb 13, 2014 |
| Countries | Australia, Canada, Puerto Rico, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: